この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2002/6/41 分で読めます
Draft Guidance for Industry: Notifying FDA of Fatalities Related to Blood Collection or Transfusion; Availability
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance document entitled "Guidance for Industry: Notifying FDA of Fatalities Related to Blood Collection or Transfusion" dated June 2002. The draft guidance document, when finalized, is intended to provide recommendations to blood collection or transfusion facilities on reporting fatalities related to blood or blood component collection or blood transfusion to FDA's Center for Biologics Evaluation and Research (CBER).
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →